InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: frrol post# 127000

Saturday, 10/28/2017 9:03:47 AM

Saturday, October 28, 2017 9:03:47 AM

Post# of 459472
My understanding is that a primary reason Ariana was hired was to focus on the best responders. Specifically, AVXL is supposedly identifying the best responders to ANAVEX2-73 by using Ariana Pharma’s KEM advanced Artificial Intelligence technology. This analysis is planned to be used to more effectively design the upcoming Phase 2/3 clinical study, potentially raising the odds of late stage trial success. Is it possible to use this analysis to improve responses in other/more patients going forward?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News